Evoke Wealth, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Evoke Wealth, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$20.56 - $63.12 $12,336 - $37,872	-600 Reduced 21.18%	2,233 $64.2 Million
Q4 2019 Feb 07, 2020	SELL	$28.14 - $73.01 $36,582 - $94,913	-1,300 Reduced 31.45%	2,833 $180 Million
Q3 2019 Nov 12, 2019	BUY	$26.26 - $34.86 $108,532 - $144,076	4,133 New	4,133 $116 Million

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.